U.S. markets closed
  • S&P Futures

    4,129.25
    +1.50 (+0.04%)
     
  • Dow Futures

    33,711.00
    +2.00 (+0.01%)
     
  • Nasdaq Futures

    13,755.50
    +5.25 (+0.04%)
     
  • Russell 2000 Futures

    2,236.20
    +7.90 (+0.35%)
     
  • Crude Oil

    61.78
    +0.35 (+0.57%)
     
  • Gold

    1,784.00
    +2.00 (+0.11%)
     
  • Silver

    26.16
    -0.02 (-0.08%)
     
  • EUR/USD

    1.2019
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.5540
    -0.0100 (-0.64%)
     
  • Vix

    18.71
    +1.21 (+6.91%)
     
  • GBP/USD

    1.3840
    -0.0003 (-0.02%)
     
  • USD/JPY

    107.9110
    -0.0490 (-0.05%)
     
  • BTC-USD

    51,669.46
    -2,168.39 (-4.03%)
     
  • CMC Crypto 200

    1,189.65
    -53.40 (-4.30%)
     
  • FTSE 100

    6,938.24
    +42.95 (+0.62%)
     
  • Nikkei 225

    29,188.17
    0.00 (0.00%)
     

Company News for Apr 7, 2021

Zacks Equity Research
·1 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Illumina Inc.'s ILMN shares jumped 7.9% after the company said that its first-quarter 2021 revenues will be better-than-expected.

  • Novavax Inc.'s NVAX shares rose 0.8% following the company's decision to consider recruiting children and teens for its COVID-19 vaccine trial by the second quarter.

  • Shares of Moderna Inc. MRNA gained 2.8% after the company extended its partnership with manufacturer Catalent for COVID-19 vaccine and other pipeline products.

  • Shares of BP p.l.c. BP surged 3.5% after the company provided a rosy outlook for 2021 supported by higher energy prices and signs of industry rebound from pandemic-ridden 2020.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Moderna, Inc. (MRNA) : Free Stock Analysis Report
 
Novavax, Inc. (NVAX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research